Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 4/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.46 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.41 |
| ▸ | MAOA | P21397 | 2/20 | 0.41 |
| ▸ | MAOB | P27338 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.39 |
| ▸ | BRD4 | O60885 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14418888 | 0.89 | CYP3A4 (0.46) | CYP3A4CYP2C9CYP2C19CHRM2RAB9A | |
| SCHEMBL14418887 | 0.87 | CYP3A4 (0.48) | CYP3A4CYP2C9CYP2C19CHRM2RAB9A | |
| SCHEMBL14425195 | 0.86 | CYP3A4 (0.45) | CYP3A4CYP2C9CYP2C19CHRM2RAB9A | |
| SCHEMBL6964877 | 0.83 | CYP3A4 (0.66) | CYP3A4CYP2C9CYP2C19MAOAMAOB | |
| SCHEMBL9705868 | 0.83 | CYP2C9 (0.45) | CYP3A4CYP2C9CYP2C19CHRM2RAB9A | |
| SCHEMBL4031265 | 0.82 | RAB9A (0.43) | CYP3A4CYP2C9CYP2C19CHRM2RAB9A | |
| SCHEMBL6964377 | 0.81 | CYP3A4 (0.64) | CYP3A4CYP2C9CYP2C19CYP1A2BRD4 | |
| SCHEMBL8300334 | 0.81 | RAB9A (0.50) | CHRM2RAB9ACYP1A2CYP2D6SMN1; SMN2 | |
| SCHEMBL6959718 | 0.78 | MEN1 (0.43) | CYP3A4CYP2C9CYP2C19CHRM2RAB9A | |
| SCHEMBL6964617 | 0.77 | CYP3A4 (0.62) | CYP3A4CYP2C9CYP2C19CYP1A2BRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0767172-B1 | 8-Arylalkyl- and 8-arylheteroalkyl-5, 11-dihydro-6H-dipyrido-[3,2-b:2', 3'-e][1,4]diazepines and their use in the prevention or treatment of HIV infection | BOEHRINGER INGELHEIM PHARMA (US) | 2003-03-26 | — | — | EP | disclosed |
| US-5705499-A | VIRICIDES | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 1998-01-06 | — | — | US | disclosed |
| EP-0767172-A1 | 8-Arylalkyl- and 8-arylheteroalkyl-5, 11-dihydro-6H-dipyrido-[3,2-b:2', 3'-e][1,4]diazepines and their use in the prevention or treatment of HIV infection | BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) | 1997-04-09 | — | — | EP | disclosed |